The Board of Directors at their Meeting held today, discussed and accepted the Resignation of Mr. Indirakumar from the position of Whole-time Director with effect from the closing hours ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd informed the stock exchanges that its Board of Directors, at a meeting held on 24 March 2026, accepted the resignation of Mr. Singarababu Indirakumar (DIN: 00892351) from the position of Whole-time Director, effective from the close of business hours on the same day. The reason cited is 'professional reasons.' An internal email trail shows Mr. Indirakumar had already communicated his resignation to the Registrar of Companies on 16 March 2026, a week before the board formally accepted it, and flagged that the meeting notice sent to him was not needed. The company has not yet announced a replacement. The disclosure was made under SEBI's Listing Regulations.
The departure of a Whole-time Director (a Key Managerial Personnel) may raise short-term governance and continuity concerns among shareholders, especially for a small-cap company. Until a replacement is appointed, investors may view this as a period of leadership uncertainty, which could weigh on sentiment around the stock.